Compare Novavax Inc (NVAX) vs Sunrun Inc (RUN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Sunrun Inc — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while Sunrun Inc trades at $11.45 (market cap $2.73B). The key difference: Sunrun Inc is far larger — about 2.1× Novavax Inc's market cap, and Novavax Inc is trading nearer its 52-week high, Sunrun Inc nearer its low. Which is the better fit depends on your goals.
| NVAX | RUN | |
|---|---|---|
Market Cap | $1.30B | $2.73B |
Sector | Health | Technology |
52-Week High | $11.19 | $21.41 |
52-Week Low | $6.22 | $9.07 |
Enterprise Value | $800.50M | $16.92B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Sunrun Inc
Sunrun Inc. is one of the largest residential solar, battery storage, and energy services companies in the United States. The company provides solar panel installations, battery backup systems, and energy management solutions to homeowners. Sunrun primarily uses a solar-as-a-service model, offering customers solar leases and power purchase agreements (PPAs), which allow homeowners to adopt solar energy with little to no upfront cost. The company's mission is to create a planet run by the sun.
Read more on RUN →
